The global predictive biomarkers market is on the brink of a significant transformation, with strong momentum building across diagnostics, drug development, and personalized medicine. According to recent findings by Foreclaro Global Research, the market was valued at approximately USD 23.9 billion in 2024 with an estimated compound annual growth rate (CAGR) of 18.1% over the forecast period.
This explosive growth is being driven by a shift in healthcare toward precision-based approaches. Predictive.
Know more